European Union summary report based on data on antimicrobial resistance in zoonotic and indicator bacteria in 2015, submitted by 28 EU Member States (MSs), jointly analysed by EFSA and ECDC.
In July 2014, a panel of two viable isolates of N. meningitidis of the major disease-causing serogroups with three simulated cerebrospinal fluid (non-culture) samples for molecular studies, was sent by UK NEQAS to 30 reference laboratories in the IBD-labnet surveillance network for quality assessment testing. This report summarises the diagnostic results submitted by the participating laboratories.
Laboratories should receive clinical and epidemiological information for establishing their investigation strategy, including date of onset of illness, travel history (date and locations), past flaviviral immunisation records and pregnancy status.
This document aims to present an algorithm for deciding whom to test and provide guidance on the laboratory tests for Zika virus infection diagnosis in order to support clinical diagnostic and case reporting through surveillance among EU Member States.